Literature DB >> 14579379

Targeted gene knockdown in zebrafish using negatively charged peptide nucleic acid mimics.

Karen A Urtishak1, Michael Choob, Xiaobing Tian, Nitzan Sternheim, William S Talbot, Eric Wickstrom, Steven A Farber.   

Abstract

Negatively charged homo-oligomers of alternating trans-4-hydroxy-L-proline/phosphonate polyamides with DNA bases (HypNA-pPNA) display excellent hybridization properties toward DNA and RNA, while preserving the mismatch discrimination, nuclease resistance, and protease resistance of peptide nucleic acids (PNAs). Similar properties are associated with morpholino phosphorodiamidate (MO) DNA mimics, which have been used in the model vertebrate zebrafish (Danio rerio) for genome-wide, sequence-based, reverse genetic screens during embryonic development. We evaluated mixed sequence HypNA-pPNAs as an alternative to MOs, and found that even a single central DNA mismatch lowered the HypNA-pPNA melting temperature by 16 degrees C. We then observed that the melting temperatures of HypNA-pPNA 18-mers hybridized to RNA 25-mers were comparable to the melting temperatures of MO 25-mers, and that two HypNA-pPNA mismatches lowered the melting temperature with RNA by 18 degrees C. In zebrafish embryos we observed that HypNA-pPNA 18-mers displayed comparable potency to MO 25-mers as knockdown agents against chordin, notail, and uroD, with greater mismatch stringency. Finally we observed that a specific HypNA-pPNA 18-mer elicited the dharma (bozozok)(-/-) phenotype in zebrafish embryos, which MO 25-mers do not. HypNA-pPNAs designed to inhibit translation of specific zebrafish RNA targets thus demonstrated stringent hybridization properties, relative to DNA and MO oligomers, and present a valuable alternative for reverse genetic studies, enabling the targeting of previously inaccessible genes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579379     DOI: 10.1002/dvdy.10394

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  16 in total

Review 1.  Chemical technologies for probing embryonic development.

Authors:  Ilya A Shestopalov; James K Chen
Journal:  Chem Soc Rev       Date:  2008-05-07       Impact factor: 54.564

Review 2.  Oligonucleotide-based tools for studying zebrafish development.

Authors:  Ilya A Shestopalov; James K Chen
Journal:  Zebrafish       Date:  2010-03       Impact factor: 1.985

Review 3.  Modelling inborn errors of metabolism in zebrafish.

Authors:  Kim Wager; Fahad Mahmood; Claire Russell
Journal:  J Inherit Metab Dis       Date:  2014-05-06       Impact factor: 4.982

Review 4.  Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol.

Authors:  Jennifer L Anderson; Juliana D Carten; Steven A Farber
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 5.  Synthetic strategies for studying embryonic development.

Authors:  Xiaohu Ouyang; James K Chen
Journal:  Chem Biol       Date:  2010-06-25

Review 6.  Translational control of gene function through optically regulated nucleic acids.

Authors:  Kristie E Darrah; Alexander Deiters
Journal:  Chem Soc Rev       Date:  2021-11-29       Impact factor: 54.564

Review 7.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

Review 8.  Zebrafish: a model system for the study of eye genetics.

Authors:  James M Fadool; John E Dowling
Journal:  Prog Retin Eye Res       Date:  2007-09-07       Impact factor: 21.198

9.  Versatile synthesis and rational design of caged morpholinos.

Authors:  Xiaohu Ouyang; Ilya A Shestopalov; Surajit Sinha; Genhua Zheng; Cameron L W Pitt; Wen-Hong Li; Andrew J Olson; James K Chen
Journal:  J Am Chem Soc       Date:  2009-09-23       Impact factor: 15.419

10.  Side chain modified peptide nucleic acids (PNA) for knock-down of six3 in medaka embryos.

Authors:  Sebastian Dorn; Narges Aghaallaei; Gerlinde Jung; Baubak Bajoghli; Birgit Werner; Holger Bock; Thomas Lindhorst; Thomas Czerny
Journal:  BMC Biotechnol       Date:  2012-08-17       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.